Cresco Labs (OTCMKTS:CRLBF – Get Free Report) is projected to announce its results before the market opens on Friday, November 6th. Analysts expect the company to announce earnings of ($0.02) per share and revenue of $173.66 million for the quarter.
Cresco Labs (OTCMKTS:CRLBF – Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.06. The company had revenue of $173.34 million during the quarter, compared to the consensus estimate of $166.20 million. Cresco Labs had a negative return on equity of 7.53% and a negative net margin of 15.50%. On average, analysts expect Cresco Labs to post ($0.04) EPS for the current fiscal year and ($0.02) EPS for the next fiscal year.
Cresco Labs Trading Up 4.5%
Shares of OTCMKTS:CRLBF opened at $0.63 on Wednesday. The company has a debt-to-equity ratio of 1.66, a quick ratio of 0.98 and a current ratio of 1.78. Cresco Labs has a twelve month low of $0.55 and a twelve month high of $2.30. The firm has a 50 day simple moving average of $0.69 and a 200-day simple moving average of $0.86.
Wall Street Analysts Forecast Growth
Several equities analysts have issued reports on the stock. Zacks Research raised shares of Cresco Labs from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, October 6th. Alliance Global Partners reaffirmed a “buy” rating on shares of Cresco Labs in a research note on Thursday, August 6th. Two analysts have rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company’s stock. According to MarketBeat, Cresco Labs presently has an average rating of “Strong Buy”.
Check Out Our Latest Report on Cresco Labs
Cresco Labs Company Profile
Cresco Labs Inc is a Chicago-based cannabis company that cultivates, manufactures and distributes cannabis products in the United States. Founded in 2013, the company operates as a multistate cannabis operator, serving regulated markets through a combination of wholesale operations and retail dispensaries.
The company’s product portfolio includes flower, pre-rolls, vape products, concentrates, edibles and other cannabis-related goods. Its principal brands have included Cresco, High Supply, Good News, Wonder Wellness, FloraCal Farms and Mindy’s Edibles.
Further Reading
- Five stocks we like better than Cresco Labs
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
- Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
- Apple’s Earnings Beat Comes With a Catch for Investors Heading Into the Holidays
- Palantir’s $2.3 Billion Quarter Puts Its Premium Valuation to the Test
Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.
